Rise in user fees in Greece could reduce access to healthcare, charity warns

Rather than try to renegotiate payment to medical professionals,
Greece has an ideal opportunity to become the first European State to
alter what has been an unreasonable and inequitable longstanding
relationship where the taxpayer funds the executive arm of the private
pharmaceutical industry rather than the latter funding it's own
professionals. I cannot think of any other industry whose products are
monopolised, marketed and distributed by self-employed professionals where
the latter are paid solely from the public purse.

Not only would this measure ensure that doctors are funded by the
corporations which employ and vest them in their services, but also the
public would begin to understand that vested interest long existing
between the pharmaceutical industry and medical physicians and become more
capable of making the right choices in seeking medical, complementary
medical and alternative medical care.